Back to Screener

Healthcare

Fielmann AG(FLMNY)

Live Price

Offline

$9.94

+0.00% today

1Y Change

-22.38%

Window

Jun 26, 2025 โ†’ Jun 23, 2026

Market Cap
$3.57B
Revenue Growth
+3.3%
EPS Growth
+29.3%
Dividend Yield
2.7%

Coverage: 253 bars ยท Jun 26, 2025 โ†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Fielmann AG (FLMNY) is a Healthcare stock with a market cap of $3.57B and listed on OTC. The stock last traded around $9.94 and down 22.4% across the available one-year price window (Jun 26, 2025 โ†’ Jun 23, 2026). Baseline metrics include revenue growth of +3.3%, EPS growth of +29.3%, a dividend yield of 2.7%. What stands out right now is revenue +3.3%, EPS +29.3%, free cash flow +3.3% with operating margin 13.3% and ROIC 11.8%. The dividend matters to the case here, with a current yield around 2.7%. Valuation is more restrained than many high-expectation growth names at P/E 17.5 and price/sales 1.5. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines FLMNY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

FLMNY vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

FLMNY

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

FLMNY Max Drawdown

-32.96%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for FLMNY and SPY.

Calendar-year return history is still loading or unavailable.

Unable to load analyst forecasts.

Timed out loading forecasts for FLMNY

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.